Canada markets closed
  • S&P/TSX

    20,571.30
    -50.09 (-0.24%)
     
  • S&P 500

    4,410.13
    +12.19 (+0.28%)
     
  • DOW

    34,364.50
    +99.13 (+0.29%)
     
  • CAD/USD

    0.7914
    -0.0034 (-0.43%)
     
  • CRUDE OIL

    84.04
    +0.73 (+0.88%)
     
  • BTC-CAD

    46,171.57
    -96.79 (-0.21%)
     
  • CMC Crypto 200

    839.82
    +29.22 (+3.60%)
     
  • GOLD FUTURES

    1,843.00
    +1.30 (+0.07%)
     
  • RUSSELL 2000

    2,033.51
    +45.59 (+2.29%)
     
  • 10-Yr Bond

    1.7350
    -0.0120 (-0.69%)
     
  • NASDAQ futures

    14,479.75
    -21.25 (-0.15%)
     
  • VOLATILITY

    29.90
    +1.05 (+3.64%)
     
  • FTSE

    7,297.15
    -196.98 (-2.63%)
     
  • NIKKEI 225

    27,588.37
    +66.11 (+0.24%)
     
  • CAD/EUR

    0.6988
    -0.0016 (-0.23%)
     

Supernus Pharmaceuticals, inc (SUPN) Q3 2021 Earnings Call Transcript

·32 min read
Supernus Pharmaceuticals, inc (SUPN) Q3 2021 Earnings Call Transcript
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • SUPN

Good afternoon, everyone, and thank you for joining us today for Supernus Pharmaceuticals' Third Quarter 2021 Financial Results Conference Call. On the call with me today are Supernus' Chief Executive Officer, Jack Khattar; and Chief Financial Officer, Tim Dec. Today's call is being made available via the Investor Relations section of the company's website at ir.supernus.com.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting